Cochrane Clinical Answers - Access Denied - How do newer continuous erythropoiesis receptor activators compare with older erythropoiesis-stimulating agents in people with anemia of chronic kidney disease?

Question:How do newer continuous erythropoiesis receptor activators compare with older erythropoiesis-stimulating agents in people with anemia of chronic kidney disease?

THIS CLINICAL ANSWER IS NEW Published Online: 9 NOV 2017

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer compares newer continuous erythropoiesis receptor activators with older erythropoiesis-stimulating agents in people with anemia of chronic kidney disease.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.